219 related articles for article (PubMed ID: 33289022)
1. Assessment of the impact of an opioid-specific education series on rates of medication-assisted treatment for opioid use disorder in veterans.
Kirby T; Connell R; Linneman T
Am J Health Syst Pharm; 2021 Feb; 78(4):301-309. PubMed ID: 33289022
[TBL] [Abstract][Full Text] [Related]
2. Associations between Medication Assisted Therapy Services Delivery and Mortality in a National Cohort of Veterans with Posttraumatic Stress Disorder and Opioid Use Disorder.
Riblet NB; Gottlieb DJ; Shiner B; Cornelius SL; Watts BV
J Dual Diagn; 2020; 16(2):228-238. PubMed ID: 31852392
[No Abstract] [Full Text] [Related]
3. Removal of prior authorization for medication-assisted treatment: impact on opioid use and policy implications in a Medicare Advantage population.
Ferries E; Racsa P; Bizzell B; Rhodes C; Suehs B
J Manag Care Spec Pharm; 2021 May; 27(5):596-606. PubMed ID: 33908274
[No Abstract] [Full Text] [Related]
4. Association of Medication-Assisted Treatment and Age With Treatment Completion Among Veterans Seeking Non-VA Treatment for Opioid use Disorder at Non-Veterans Health Administration Facilities.
Pickard JG; van den Berk-Clark C; Matthieu MM
Mil Med; 2022 Mar; 187(3-4):504-512. PubMed ID: 34173832
[TBL] [Abstract][Full Text] [Related]
5. A Retrospective 4-year Outcome Study of Veterans Admitted to an Acute Inpatient Detoxification Unit for Opioid Use Disorder.
Li KJ; Smedberg DL; DeLisi LE
Am J Addict; 2019 Jul; 28(4):318-323. PubMed ID: 31067001
[TBL] [Abstract][Full Text] [Related]
6. Barriers and facilitators to implementing medications for opioid use disorder and naloxone distribution in Veterans Affairs emergency departments.
Sasson C; Dieujuste N; Klocko R; Basrai Z; Celedon M; Hsiao J; Himstreet J; Hoffman J; Pfaff C; Malmstrom R; Smith J; Holstein A; Johnson-Koenke R
Acad Emerg Med; 2023 Apr; 30(4):289-298. PubMed ID: 36757683
[TBL] [Abstract][Full Text] [Related]
7. The Role of Primary Care in Improving Access to Medication-Assisted Treatment for Rural Medicaid Enrollees with Opioid Use Disorder.
Cole ES; DiDomenico E; Cochran G; Gordon AJ; Gellad WF; Pringle J; Warwick J; Chang CH; Kim JY; Kmiec J; Kelley D; Donohue JM
J Gen Intern Med; 2019 Jun; 34(6):936-943. PubMed ID: 30887440
[TBL] [Abstract][Full Text] [Related]
8. The impact of an emergency department peer navigator (EDPN) program in improving clinical outcomes and healthcare utilization in an urban setting.
Santos C; Ramdin C; Becceril J; Al Kik B; Jefri M; Nelson L
Am J Emerg Med; 2023 Jun; 68():10-16. PubMed ID: 36905880
[TBL] [Abstract][Full Text] [Related]
9. Epidemiological study of opioid use disorder in French emergency departments, 2010-2018 from OSCOUR database.
Gallien Y; Martin A; Caserio-Schönemann C; Le Strat Y; Thiam MM
BMJ Open; 2020 Oct; 10(10):e037425. PubMed ID: 33127629
[TBL] [Abstract][Full Text] [Related]
10. Polysubstance use and association with opioid use disorder treatment in the US Veterans Health Administration.
Lin LA; Bohnert ASB; Blow FC; Gordon AJ; Ignacio RV; Kim HM; Ilgen MA
Addiction; 2021 Jan; 116(1):96-104. PubMed ID: 32428386
[TBL] [Abstract][Full Text] [Related]
11. Organizational factors associated with practitioners' support for treatment of opioid use disorder in the emergency department.
Guerrero E; Ober AJ; Howard DL; Khachikian T; Kong Y; van Deen WK; Valdez A; Trotzky-Sirr R; Menchine M
Addict Behav; 2020 Mar; 102():106197. PubMed ID: 31862684
[TBL] [Abstract][Full Text] [Related]
12. Adverse Consequences of Co-Occurring Opioid Use Disorder and Cannabis Use Disorder Compared to Opioid Use Disorder Only.
De Aquino JP; Sofuoglu M; Stefanovics E; Rosenheck R
Am J Drug Alcohol Abuse; 2019; 45(5):527-537. PubMed ID: 31112429
[No Abstract] [Full Text] [Related]
13. Factors associated with opioid overdose during medication-assisted treatment: How can we identify individuals at risk?
Au VYO; Rosic T; Sanger N; Hillmer A; Chawar C; Worster A; Marsh DC; Thabane L; Samaan Z
Harm Reduct J; 2021 Jul; 18(1):71. PubMed ID: 34238301
[TBL] [Abstract][Full Text] [Related]
14. Emergency department presentation of opioid use disorder and alcohol use disorder.
Xierali IM; Day PG; Kleinschmidt KC; Strenth C; Schneider FD; Kale NJ
J Subst Abuse Treat; 2021 Aug; 127():108343. PubMed ID: 34134862
[TBL] [Abstract][Full Text] [Related]
15. Healthcare costs and use before and after opioid overdose in Veterans Health Administration patients with opioid use disorder.
Joyce VR; Oliva EM; Garcia CC; Trafton J; Asch SM; Wagner TH; Humphreys K; Owens DK; Bounthavong M
Addiction; 2023 Nov; 118(11):2203-2214. PubMed ID: 37465971
[TBL] [Abstract][Full Text] [Related]
16. Impact of Office-based Opioid Treatment on Emergency Visits and Hospitalization in Adolescents with Opioid Use Disorder.
Walker KS; Bonny AE; McKnight ER; Nahata MC
J Pediatr; 2020 Apr; 219():236-242. PubMed ID: 32044099
[TBL] [Abstract][Full Text] [Related]
17. Age related medication for addiction treatment (MAT) use for opioid use disorder among Medicaid-insured patients in New York.
Neighbors CJ; Choi S; Healy S; Yerneni R; Sun T; Shapoval L
Subst Abuse Treat Prev Policy; 2019 Jun; 14(1):28. PubMed ID: 31238952
[TBL] [Abstract][Full Text] [Related]
18. Systematic content analysis of patient evaluations of START NOW psychotherapy reveals practical strategies for improving the treatment of opioid use disorder.
Truong AY; Saway BF; Bouzaher MH; Rasheed MN; Monjazeb S; Everest SD; Giampalmo SL; Hartman D; Hartman C; Kablinger AS; Trestman RL
BMC Psychiatry; 2021 Jan; 21(1):23. PubMed ID: 33423661
[TBL] [Abstract][Full Text] [Related]
19. Patient-Reported Goals of Youths in Canada Receiving Medication-Assisted Treatment for Opioid Use Disorder.
Chai D; Rosic T; Panesar B; Sanger N; van Reekum EA; Marsh DC; Worster A; Thabane L; Samaan Z
JAMA Netw Open; 2021 Aug; 4(8):e2119600. PubMed ID: 34351402
[TBL] [Abstract][Full Text] [Related]
20. Sex Differences in Opioid Use Disorder Prevalence and Multimorbidity Nationally in the Veterans Health Administration.
Peltier MR; Sofuoglu M; Petrakis IL; Stefanovics E; Rosenheck RA
J Dual Diagn; 2021; 17(2):124-134. PubMed ID: 33982642
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
